Filter by: patients
Home > Community Treatment Reports and Side Effects > Rituximab Treatment Report
What is Rituximab?

Rituximab is an injectable drug that is in a class of medications called monoclonal antibiodies. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Neuromyelitis Optica 30 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
MS (Multiple Sclerosis) 24 12 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 11 3 Efficacy_moderate Efficacy_slight
RA (Rheumatoid Arthritis) 7 3 Efficacy_major Efficacy_cant_tell
Relapse MS (exacerbation) 3 0
Systemic Lupus Erythematosus 2 1 Efficacy_major

See all 61 patients currently taking Rituximab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 5
Moderate
 4
Mild
 14
None
 15

Commonly reported side effects, conditions, and hospitalizations associated with Rituximab

Allergic reaction 3
Migraine headaches 2
Low blood pressure 1
Bladder problems 1
Blurry vision 1
Diarrhea 1
See all 19 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Rituximab. See all 37 dosages ►

  1g as needed 1,000mg as needed 10mg/mL as needed 2 mg yearly 10 mg yearly 10 mg every 3 months 1,000 mg yearly 500 mg every 3 months 1,000 mg every 3 months 1,000 mg every other week
  3 Number of Patients: 3 3 Number of Patients: 3 7 Number of Patients: 7 1 Number of Patients: 1 4 Number of Patients: 4 7 Number of Patients: 7 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Rituximab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 21   Course of treatment ended: 42%
Did not seem to work 11   Did not seem to work: 22%
Doctor's advice 10   Doctor's advice: 20%
Side effects too severe 8   Side effects too severe: 16%
Other 7   Other: 14%
Not indicated 6   Not indicated: 12%
Expense 1   Expense: 2%

See all 50 patients who’ve stopped taking Rituximab

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rituximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Rituximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rituximab

Always
 32 84%
Usually
 1 3%
Sometimes
 2 5%
Never
 3 8%

Burden

Difficulty being on treatment

Burden of Rituximab

Very
 2 5%
Somewhat
 14 37%
A little
 11 29%
Not at all
 11 29%

Cost

Paid out of pocket

Cost of Rituximab

$200+
 7 32%
$100-199
 3 14%
$50-99
 0 0%
$25-49
 0 0%
< $25
 11 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 10, 2012.